Steatohepatitic hepatocellular carcinoma: Two cases report with literature review

  • Dao Thi Huyen 108 Military Central Hospital
  • Le Thi Thanh Xuan 108 Military Central Hospital
  • Le Duy Dung 108 Military Central Hospital
  • Le Thi Trang 108 Military Central Hospital
  • Le Minh Son 108 Military Central Hospital
  • Le Minh Son 108 Military Central Hospital
  • Ngo Thi Minh Hanh 108 Military Central Hospital

Main Article Content

Keywords

Steatohepatitic hepatocellular carcinoma, hepatocellular carcinoma

Abstract

Steatohepatitic hepatocellular carcinoma (SH-HCC) is one of the most common hepatocellular carcinoma (HCC) subtypes, with a frequency of 5-20%. These tumor are well-differentiated and show distinct histologic features resembling steatohepatitis: Macrovesicular steatosis, inflammation, balloon cells, Mallory-Denk bodies and pericellular fibrosis. Because of their similar characteristics, distinguishing SH-HCC from background fatty liver can be a diagnostic challenge. The histology of SH-HCC has been described in resection specimens. Unfortunately, diagnostic criteria to aid in the evaluation of biopsy specimens have not been well established; therefore, the diagnosis of SH-HCC in biopsies remains challenging. On diagnostic imaging tests, SH-HCC may be difficult to distinguish from surrounding liver parenchyma in patients with severe hepatic steatosis or other fat-containing liver lesions such as angiomyolipoma or clear cell HCC. We report two cases of SH-HCC that we documented along with diagnostic difficulties.

Article Details

References

1. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA; WHO Classification of Tumours Editorial Board (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76(2): 182-188. doi: 10.1111/his.13975.
2. Jabbour TE, Lagana SM and Lee H (2019) Update on hepatocellular carcinoma: Pathologists’ review. WJG 25(14): 1653-1665.
3. Kim H, Jang M and Park YN (2020) Histopathological variants of hepatocellular carcinomas: An update according to the 5th Edition of the WHO classification of digestive system tumors. JLC 20(1): 17-24.
4. Loy LM, Low HM, Choi JY et al (2022) Variant hepatocellular carcinoma subtypes according to the 2019 WHO classification: An imaging-focused review. American Journal of Roentgenology, 219(2): 212–223.
5. Olofson AM, Gonzalo DH, Chang M et al (2018) Steatohepatitic variant of hepatocellular carcinoma: A focused review. Gastroenterol Res 11(6): 391-396.
6. Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH (2010) Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Am J Surg Pathol 34: 1630-1636.
7. Salomao M, Remotti H, Vaughan R, Siegel AB, Lefkowitch JH, Moreira RK (2012) The steatohepatitic variant of hepatocellular carcinoma. Human Pathology 43: 737-746.
8. Torbenson MS and Yeh MM (2021) Steatohepatitic hepatocellular carcinoma. Hepatoma Res 2021 7: 38.